Advertisement

Gender and Polypharmacotherapy in the Elderly: A Clinical Challenge

  • Christina Hofer-Dückelmann
Chapter
Part of the Handbook of Experimental Pharmacology book series (HEP, volume 214)

Abstract

Polypharmacotherapy is a major concern in the elderly and especially in older women after the age of 80. It results from the intake of prescription and non-prescription drugs, being often a problem of evidence-based therapy. Besides the fact that women live longer than men and outnumber them, reasons for polypharmacy in women are diverse and include a different attitude towards intake of drugs between men and women, the propensity of women to rather see a physician and talk about their problems, the load of family responsibility as women are the main caregivers within a family, the influence of physician sex on patient care, the level of education, social deprivation and self-rated health. Women are more often prescribed potentially inappropriate medication and more often become victims of adverse drug reactions. This is not only due to the number and quality of drugs prescribed but also to differences in pharmacokinetics and - dynamics which make them more vulnerable to drug exposure. Thus, inappropriate prescribing contributes to hospitalization, poor quality of life, costs, compliance issues and poor outcomes. More preclinical and clinical studies with elderly patients and especially elderly women are needed to study the underlying mechanisms of the pharmacologic differences and obtain more insight into the difference in risk between men and women. Attention to prescribing of medications, consistent review of medication lists, and reevaluation of indications and outcomes of prescribing are essential to ensure that drugs are used appropriately in elderly women, polypharmacy is minimized and safety for patients is maximized.

Keywords

Define Daily Dose Inappropriate Medication Pain Reliever Excessive Polypharmacy Digitalis Investigation Group 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. Baranzini F, Diurni M, Ceccon F, Poloni N, Cazzamalli S, Costantini C, Colli C, Greco L, Callegari C (2009) Fall-related injuries in a nursing home setting: is polypharmacy a risk factor? BMC Health Serv Res 9:228PubMedCrossRefGoogle Scholar
  2. Barat I, Andreasen F, Damsgaard EM (2001) Drug therapy in the elderly: what doctors believe and patients actually do. Br J Clin Pharmacol 51:615–622PubMedCrossRefGoogle Scholar
  3. Beers MH (1997) Explicit criteria for determining potentially inappropriate medication use by the elderly. Arch Intern Med 157:1531–1536PubMedCrossRefGoogle Scholar
  4. Beierle I, Meibohm B, Derendorf H (1999) Gender differences in pharmacokinetics and pharmacodynamics. Int J Clin Pharmacol Ther 37(11):529–547PubMedGoogle Scholar
  5. Bierman AS, Pugh MJ, Dhalla I, Amuan M, Fincke BG, Rosen A, Berlowitz DR (2007) Sex differences in inappropriate prescribing among elderly veterans. Am J Geriatr Pharmacother 5(2):147–161PubMedCrossRefGoogle Scholar
  6. Brännström J, Hamberg K, Molander L, Lövheim H, Gustafson Y (2011) Gender disparities in the pharmacological treatment of cardiovascular disease and diabetes mellitus in the very old: an epidemiological, cross-sectional survey. Drugs Aging 28(12):993–1005PubMedCrossRefGoogle Scholar
  7. Cafferata GL, Meyers SM (1990) Pathways to psychotropic drugs. Understanding the basis of gender differences. Med Care 28(4):285–300PubMedCrossRefGoogle Scholar
  8. Campion EW, Avorn J, Reder VA, Olins NJ (1987) Overmedication of the low-weight elderly. Arch Intern Med 147(5):945–947PubMedCrossRefGoogle Scholar
  9. Chen YF, Dewey ME, Avery AJ (2001) Self-reported medication use for older people in England and Wales. J Clin Pharm Ther 26(2):129–140PubMedCrossRefGoogle Scholar
  10. Colley CA, Lucas LM (1993) Polypharmacy: the cure becomes the disease. J Gen Intern Med 8:278–283PubMedCrossRefGoogle Scholar
  11. Drici MD, Clement N (2001) Is gender a risk factor for adverse drug reactions? The example of drug-induced long QT syndrome. Drug Saf 24(8):575–585PubMedCrossRefGoogle Scholar
  12. Fulton MM, Allen ER (2005) Polypharmacy in the elderly: a literature review. J Am Acad Nurse Pract 17(4):123–132PubMedCrossRefGoogle Scholar
  13. Goulding MR (2004) Inappropriate medication prescribing for elderly ambulatory care patients. Arch Intern Med 164:305–312PubMedCrossRefGoogle Scholar
  14. Gurwitz JH (2005) The age/gender interface in geriatric pharmacotherapy. J Womens Health (Larchmt) 14(1):68–72CrossRefGoogle Scholar
  15. Haider SI, Johnell K, Thorslund M, Fastbom J (2007) Trends in polypharmacy and potential drug-drug interactions across educational groups in elderly patients in Sweden for the period 1992–2002. Int J Clin Pharmacol Ther 45(12):643–653PubMedGoogle Scholar
  16. Haider SI, Johnell K, Weitoft GR, Thorslund M, Fastbom J (2009) The influence of educational level on polypharmacy and inappropriate drug use: a register-based study of more than 600,000 older people. J Am Geriatr Soc 57(1):62–69PubMedCrossRefGoogle Scholar
  17. Hajjar ER, Cafiero AC, Hanlon JT (2007) Polypharmacy in elderly patients. Am J Geriatr Pharmacother 4:345–351CrossRefGoogle Scholar
  18. Hofer-Dueckelmann C, Prinz E, Beindl W, Syzmanski J, Fellhofer G, Pichler M, Schuler J (2011) Adverse drug reactions (ADRs) associated with hospital admissions – elderly female patients are at highest risk. Int J Clin Pharmacol Ther 49(10):577–586PubMedGoogle Scholar
  19. Holt S, Schmiedl S, Thürmann PA (2010) Potentially inappropriate medications in the elderly: the PRISCUS list. Dtsch Arztebl Int 107(31–32):543–551PubMedGoogle Scholar
  20. Howard M, Dolovich L, Kaczorowski J et al (2004) Prescribing of potentially inappropriate medications to elderly people. Fam Pract 21:244–247PubMedCrossRefGoogle Scholar
  21. Johnell K, Ringbäck G, Fastbom J (2009) Sex differences in inappropriate drug use: a register-based study of over 600,000 older people. Ann Pharmacother 43(7):1233–1238PubMedCrossRefGoogle Scholar
  22. Jörgensen T, Johansson S, Kennerfalk A, Wallander MA, Svärdsudd K (2001) Prescription drug use, diagnoses, and healthcare utilization among the elderly. Ann Pharmacother 35(9):1004–1009PubMedCrossRefGoogle Scholar
  23. Junius-Walker U, Theile G, Hummers-Pradier E (2006) Prevalence and predictors of polypharmacy among older primary care patients in Germany. Fam Pract 24(1):14–19PubMedCrossRefGoogle Scholar
  24. Jyrkka J, Enlund H, Korhonen MJ, Sulkava R, Hartikainen S (2009) Patterns of drug use and factors associated with polypharmacy and excessive polypharmacy in elderly persons: results of the Kuopio 75+ study: a cross-sectional analysis. Drugs Aging 26(6):493–503PubMedCrossRefGoogle Scholar
  25. Kennerfalk A, Ruigomez A, Wallander MA, Wilhelmsen L, Johansson S (2002) Geriatric drug therapy and healthcare utilization in the United Kingdom. Ann Pharmacother 36(5):797–803PubMedCrossRefGoogle Scholar
  26. Kim AM, Tingen CM, Woodruff TK (2010) Sex bias in trials and treatment must end. Nature 465:688–689PubMedCrossRefGoogle Scholar
  27. Krähenbühl-Melcher A, Schlienger R, Lampert M, Haschke M, Drewe J, Krähenbühl S (2007) Drug-related problems in hospitals: a review oft he recent literature. Drug Saf 30:379–407PubMedCrossRefGoogle Scholar
  28. Lagro-Janssen AL (2008) Medicine is not gender-neutral: influence of physician sex on medical care. Ned Tijdschr Geneeskd 152(20):1141–1145PubMedGoogle Scholar
  29. Lee PY, Alexander KP, Hammill BG, Sk P, Peterson ED (2001) Representation of elderly persons and women in published randomized trials of acute coronary syndromes. JAMA 286(6):708–713PubMedCrossRefGoogle Scholar
  30. Linjakumpu T, Hartikainen S, Klaukka T, Veijola J, Kivela SL, Isoaho R (2002) Use of medications and polypharmacy are increasing among the elderly. J Clin Epidemiol 55(8):809–817PubMedCrossRefGoogle Scholar
  31. Maggiore RJ, Gross CP, Hurria A (2010) Polypharmacy in older adults with cancer. Oncologist 15(5):507–522PubMedCrossRefGoogle Scholar
  32. Martin RM, Biswas PN, Freemantle SN, Pearce GL, Mann RD (1998) Age and sex distribution of suspected adverse drug reactions to newly marketed drugs in general practice in England: analysis of 48 cohorts. Br J Clin Pharmacol 46:505–511PubMedCrossRefGoogle Scholar
  33. Morse AN, Labin LC, Young SB, Aronson MP, Gurwitz JH (2004) Exclusion of elderly women from published randomized trials of stress incontinence surgery. Obstet Gynecol 104(3):498–503PubMedCrossRefGoogle Scholar
  34. Oertelt-Prigione S, Regitz-Zagrosek V (2009) Gender aspects in cardiovascular pharmacology. J Cardiovasc Transl Res 2(3):258–266PubMedCrossRefGoogle Scholar
  35. Patterns of Medication Use in the United States (2006) A report from the Slone Survey. Boston: Slone epidemiology Center at Boston University. (http://www.bu.edu/slone/SloneSurvey/AnnualRpt/SloneSurveyWebReport2006.pdf)
  36. Perry BA, Turner LW (2001) A prediction model for polypharmacy: are older, educated women more susceptible to an adverse drug event? J Women Aging 13(4):39–51PubMedCrossRefGoogle Scholar
  37. Rathore SS, Wang Y, Krumholz HM (2002) Sex-based differences in the effect of digoxin for the treatment of heart failure. N Engl J Med 347(18):1403–1411PubMedCrossRefGoogle Scholar
  38. Rochon PA, Gurwitz JH (1999) Prescribing for seniors: neither too much nor too little. JAMA 282:113–115PubMedCrossRefGoogle Scholar
  39. Rodenburg E, Stricker BH, Visser LE (2010) Sex-related differences in hospital admissions attributed to adverse drug reactions in the Netherlands. Br J Clin Pharmacol 71(1):95–104CrossRefGoogle Scholar
  40. Schuler J, Dückelmann C, Beindl W, Prinz E, Michalski T, Pichler M (2008) Polypharmacy and inappropriate prescribing in elderly internal-medicine patients in Austria. Wien Klin Wochenschr 120:733–741PubMedCrossRefGoogle Scholar
  41. Schwabe U, Paffrath D (2008) Arzneiverordnungsreport 2008. Springer Medizin Verlag, HeidelbergCrossRefGoogle Scholar
  42. Schwartz JB (2007) The current state of knowledge on age, sex and their interactions on clinical pharmacology. Clin Pharmacol Ther 82(1):87–96PubMedCrossRefGoogle Scholar
  43. Shi S, Mörike K, Klotz U (2008) The clinical implications of ageing for rational drug therapy. Eur J Clin Pharmacol 64(2):183–199PubMedCrossRefGoogle Scholar
  44. Simoni-Wastila L (1998) Gender and psychotropic use. Med Care 36(1):88–94PubMedCrossRefGoogle Scholar
  45. Sommeregger U, Iglseder B, Böhmdorfer B, Benvenuti-Falger U, Dvojak P, Lechleitner M, Otto R, Roller RE, Gosch M (2010) Polypharmacy and falls in the elderly. Wien Med Wochenschr 160(11–12):293–296PubMedCrossRefGoogle Scholar
  46. Sorensen L, Stokes JA, Purdie DM et al (2005) Medication managementat home: medication related risk factors associated with poor health outcomes. Age Ageing 34:626–632PubMedCrossRefGoogle Scholar
  47. Thürmann P, Holt S, Zawinell A (2012) Arzneimittelversorgung älterer Patienten. Beitrag für den Versorgungsreport. Günster C, Klose J, Schmacke N (eds)Google Scholar
  48. United Nations (2009) World Population Aging. Report of the United Nations, New York 2010Google Scholar
  49. van der Hooft CS, Sturkenboom MC, van Grootheest K, KIngma HJ, Stricker BH (2006) Adverse drug reaction-related hospitalizations: a nationwide study in the Netherlands. Drug Saf 29(2):161–168PubMedCrossRefGoogle Scholar
  50. Viktil KK, Blix HS, Moger TA, Reikvam A (2007) Polypharmacy as commonly defined is an indicator of limited value in the assessment of drug-related problems. Br J Clin Pharmacol 63(2):187–195PubMedCrossRefGoogle Scholar
  51. Zhan C, Sangl J, Bierman AS et al (2001) Potentially inappropriate medication use in the community dwelling elderly: findings from the 1996 medical expenditure panel survey. JAMA 286:2823–2829PubMedCrossRefGoogle Scholar
  52. Zok K (2006) Arzneimittelmarkt: Selbstmedikation im Fokus. WldO-Monitor 3(1), WldO Bonn. http://www.wido.de/fileadmin/wido/downloads/pdfwidomonitor/widomonselbstmed0506.pdf
  53. Zopf Y, Rabe C, Neubert A, Gassmann KG et al (2008) Women encounter ADRs more often than do men. Eur J Clin Pharmacol 64:999–1004PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2013

Authors and Affiliations

  1. 1.Pharmacy DepartmentLandesapotheke am St. Johanns SpitalSalzburgAustria

Personalised recommendations